DP Quality Control: How to Control Visible Particulates in Injections？1/2

December 9, 2024/in NewsRoom, Science & Technology/by chi9iua

Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing

November 12, 2024/in Corporate News, News, NewsRoom/by chi9iua

Chime Biologics Bridges Innovation and Collaboration at Europe-China Biotech Business Forum 2024

November 4, 2024/in News, NewsRoom, Uncategorized/by chi9iua

Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing

October 28, 2024/in Corporate News, News, NewsRoom/by chi9iua

Chime Biologics congratulates Hope Medicine on HMI-115's CDE Breakthrough Therapy Designation

October 24, 2024/in Corporate News, News/by chi9iua

Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics

October 9, 2024/in News, NewsRoom/by chi9iua

Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics SEATTLE, Oct. 9, 2024 /PRNewswire/ -- Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 (CDH17), is pleased to announce strategic collaborations in precision oncology using artificial intelligence (AI) to advance targeted immunotherapeutics of bispecific T-cell engagers (TCEs) and antibody-drug conjugates […]